✦ LIBER ✦

Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer

✍ Scribed by Aman Buzdar; Charles Vogel; Lee Schwartzberg; August Garin; Alejandra Perez; James Ingle; Michele Houghton; Christopher Zergebel; Bill Kimball

Book ID: 112066830
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 362 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26419

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of three doses

Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer

✍ Hideo Inaji; Hiroji Iwata; Takahiro Nakayama; Naohito Yamamoto; Yasuyuki Sato; Y 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

P82 Efficacy of double-blinding in a ran

P82 Efficacy of double-blinding in a randomized controlled trial (RCT) of low dose warfarin to prevent thromboembolic disease in patients with metastatic breast cancer

✍ Lenore Dickson; Mark Levine; Michael Gent 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Randomized Phase III Placebo-Controlled

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

✍ Wolff, A. C.; Lazar, A. A.; Bondarenko, I.; Garin, A. M.; Brincat, S.; Chow, L.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

Phase II, double-blind, randomized trial

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

✍ Mark Clemons; Anil A. Joy; Radhi Abdulnabi; Mauricio Kotliar; Jodi Lynch; Johan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 317 KB

Phase 2 trial of a novel capecitabine do

Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer

✍ Devika Gajria; Kim Feigin; Lee K. Tan; Sujata Patil; Stephanie Geneus; Maria The 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Phase 2 randomized trial of primary endo

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/